Open original FDA record ↗Recall record
- FDA identifier
- Z-0328-2022
- Company in FDA record
- Randox Laboratories Ltd.
- FDA record creation date
- Dec 1, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
When calibrating using the standard provided in the kit, the change in absorbance is lower than expected generating internal quality control results high outside range
Source facts
- Action
- Randox USA, Distributor contacted the customer via Urgent Medical Device Correction letter email on 11/1/21. The letter states reason for recall, health risk and action to take: Action to be taken: " Discontinue use of and discard any of the above batches immediately. " Review your reagent inventory of these products and assess your laboratories needs for reimbursement for discarded inventory. " Review results generated with the affected batches in line with the clinical profile of the patient. " Discuss the contents of this notice with your Medical Director. " Complete and return the response form 12187-QA to technical.services@randox.com within five working days. Transmission of Field Safety Notice: Send a copy of the FSN to all affected customers and to those who need to be aware within your organisation. If you have any questions or concerns please contact Randox Technical Services.
- Initiated
- 2021-11-01
- Root cause
- Under Investigation by firm
- Terminated
- 2023-03-09
- Distribution
- US Nationwide distribution in the states of GA, OR, PA ,WA, West Virginia.
- Recall number
- Z-0328-2022
- Recall status
- Terminated
- CDRH record ID
- 190239
- FDA record created
- 2021-12-01
- Recall event number
- 88999